Research And Markets Research And Markets
0 CHECKOUT

Competitor Analysis: Herpes Virus Vaccines and Therapeutics

  • ID: 2372834
  • December 2012
  • 56 Pages
  • La Merie Publishing
1 of 4

FEATURED COMPANIES

  • Agenus AiCuris AlphaVax
  • Bio Products Laboratory
  • CSL Behring
  • Green Cross
  • Mylan
  • Piramal Life Sciences
  • MORE

Product description

The present Competitive Intelligence Report about Herpes Virus Vaccines & Therapeutics provides a competitor evaluation in the field of prophylactic vaccines and therapeutic antibodies and small molecules against infection caused by herpes simplex virus (HSV) type 1 and/or type 2 and varicella zoster virus (VZV) or human herpes virus type 3 (HHV-3) as of December 2012. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

Herpes simplex virus 1 and 2 (HSV-1 and HSV-2), also known as Human herpes virus 1 and 2 (HHV-1 and -2), are two members of the herpes virus family that infect humans. HSV-1 and HSV-2 cause the viral disease herpes simplex which can be categorized into one of several distinct disorders based on the site of infection: oral herpes with the visible symptoms of cold sores or fever blisters, genital herpes and other forms including ocular herpes (keratitis).

Varicella zoster virus (VZV) is another of eight herpes viruses known to infect humans. It commonly causes chicken-pox in children and both shingles and postherpetic neuralgia in adults and rarely in children. Varicella zoster virus is known by many names, including: chickenpox virus, varicella virus, zoster virus, and human herpes virus type 3 (HHV-3).

The report includes a compilation of marketed and currently active projects in READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Agenus AiCuris AlphaVax
  • Bio Products Laboratory
  • CSL Behring
  • Green Cross
  • Mylan
  • Piramal Life Sciences
  • MORE

- Varicella zoster virus (VZV) Vaccines
- Herpes Simplex Virus (HSV) type 1/2 Vaccines
- HSV Antibodies
- HSV Small Molecules
- Herpetic Keratitis
- Corporate Herpes Virus Vaccine & Therapeutic R&D Pipelines

Note: Product cover images may vary from those shown
3 of 4

- Agenus AiCuris AlphaVax
- Anhui Anke Biotechnology
- aRigen Pharmaceuticals
- Asahi Kasei Pharma
- ausch + Lomb
- Beech Tree Labs
- BIKEN
- Bio Products Laboratory
- BioAlliance Pharma
- Biotest
- BTA Pharmaceuticals
- Cangene
- Changchun Institute of Biological Products
- Chimerix
- Coridon
- CSL Behring
- CSL Biotherapies
- Development Center for Biotechnology
- Epiphany Biosciences
- Functional Genetics
- Genocea Biosciences
- GenVec
- GlaxoSmithKline
- Green Cross
- Immune Design
- Lumavita
- Medivir
- Meda
- Menarini
- Merck & Co
- Mylan
- Mymetics
- NanoBio
- NanoViricides
- New American Therapeutics
- NIAID
- Novartis
- Piramal Life Sciences
- Resolvyx Pharmaceuticals
- Roxane Laboratories
- Sanofi Pasteur
- Shanghai Institute of Biological Products
- Shenzhen Neptunus Interlong Biotechnique Company
- Sinovac Biotech
- Southern Illinolis School of Medicine
- Starpharma
- Synergy Pharmaceuticals
- Teva Pharmaceutical Industries
- Trigon Biotechnological
- Valeant Pharmaceuticals
- Vical
- Watson Pharmaceuticals

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

RELATED PRODUCTS from Db